S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Cogent Biosciences (COGT) Earnings Date, Estimates & Call Transcripts

$6.71
+0.10 (+1.51%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 26)
-$0.63 Missed By -$0.08
Consensus EPS
(Feb. 26)
-$0.55
Skip Charts & View Estimated and Actual Earnings Data

COGT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

COGT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cogent Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.55)($0.51)($0.53)
Q2 20243($0.53)($0.43)($0.49)
Q3 20243($0.56)($0.40)($0.49)
Q4 20243($0.56)($0.37)($0.49)
FY 202412($2.20)($1.71)($1.99)
Q1 20251($0.36)($0.36)($0.36)
Q2 20251($0.35)($0.35)($0.35)
Q3 20251($0.35)($0.35)($0.35)
Q4 20251($0.34)($0.34)($0.34)
FY 20254($1.40)($1.40)($1.40)

COGT Earnings Date and Information

Cogent Biosciences last released its quarterly earnings data on February 26th, 2024. The technology company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by $0.08. Cogent Biosciences has generated ($2.40) earnings per share over the last year (($2.40) diluted earnings per share). Earnings for Cogent Biosciences are expected to grow in the coming year, from ($1.89) to ($1.71) per share. Cogent Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Cogent Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
2/26/2024Q4 2023($0.55)($0.63)($0.08)($0.63)--
11/2/2023Q3 2023($0.50)($0.64)($0.14)($0.64)--
8/8/2023Q2 2023($0.53)($0.59)($0.06)($0.59)--
5/9/2023Q1 2023($0.58)($0.54)+$0.04($0.54)--
3/14/2023Q4 2022($0.50)($0.56)($0.06)($0.56)--
11/14/2022Q3 2022($0.51)($0.50)+$0.01($0.50)--
8/9/2022Q2 2022($0.64)($0.71)($0.07)($0.71)--
5/10/2022Q1 2022($0.53)($0.68)($0.15)($0.68)--    
3/15/2022Q4 2021($0.55)($0.61)($0.06)($0.61)--
11/10/2021Q3($0.4060)($0.48)($0.0740)($0.48)--
8/15/2021Q2 2021($0.36)($0.43)($0.07)($0.43)--
5/11/2021Q1 2021($0.28)($0.34)($0.06)($0.34)--

Cogent Biosciences Earnings - Frequently Asked Questions

When is Cogent Biosciences's earnings date?

Cogent Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on COGT's earnings history.

Did Cogent Biosciences beat their earnings estimates last quarter?

In the previous quarter, Cogent Biosciences (NASDAQ:COGT) missed the analysts' consensus estimate of ($0.55) by $0.08 with a reported earnings per share (EPS) of ($0.63). Learn more on analysts' earnings estimate vs. COGT's actual earnings.

How much profit does Cogent Biosciences generate each year?

Cogent Biosciences (NASDAQ:COGT) has a recorded net income of -$192.41 million. COGT has generated -$2.40 earnings per share over the last four quarters.

What is Cogent Biosciences's EPS forecast for next year?

Cogent Biosciences's earnings are expected to grow from ($1.89) per share to ($1.71) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:COGT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners